title: [Tubo-ovarian actinomycosis, intrauterine device and chemotherapy for breast cancer].
abstract: Tubo-ovarian actinomycosis was observed after chemotherapy for breast cancer in a patient with an intrauterine device. Does chemotherapy increase the risk? How can it be prevented?
authors.affiliation: Service de Gynécologie-Obstétrique, Centre Hospitalier, Thonon.
authors.forename: J
authors.initials: J
authors.lastname: Salvat
authors.forename: L
authors.initials: L
authors.lastname: Slamani
authors.forename: J F
authors.initials: JF
authors.lastname: Knopf
authors.forename: C
authors.initials: C
authors.lastname: Nicora
mesh_terms: D000196:Actinomycosis / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D005184:Fallopian Tube Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D008875:Middle Aged; D010049:Ovarian Diseases / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents